CD8A and sexually transmitted disease: In contrast, the variables associated with the clinical events were the number of documented STIs, number of previous comorbidities, CD8+ T-cell count, drug consumption, time since HIV diagnosis to starting ART, FIB-4 fibrosis stage, and time since HCV diagnosis to treatment with DAAs.